Q&A with Bill Gianoukos, CEO at Goodpath

Media 7 | September 14, 2021

Bill Gianoukos, Co-founder and CEO of Goodpath, started Goodpath in 2018 with a mission to improve the ‘Quality Of Life’ for those suffering from chronic conditions. He is also a Mentor at Techstars, and an Investor at Wappier: Intelligent Revenue Management.

We miss sleep. We ‘walk it off’ again and again. We live on a pill and a prayer. And all the while, these nagging issues become something that compound, ultimately impacting everything else in our bodies (and multiplying those quality-of-life issues).



MEDIA 7: Could you please walk us through your professional journey of over two decades and what brought you to this specific career path?
BILL GIANOUKOS:
I started my career in engineering, focusing on software and solutions. After a few years, I went on to co-found HeyWire. The company’s platform allowed businesses to chat with their customers in seamless, two-way texts, even from a landline. It opened modes of communication that larger corporations didn’t have reliable access to before, and I went on to sell Heywire to Salesforce in 2014. It's now the Salesforce LiveMessage system. After HeyWire, Carl Nehme and I founded TrumpIt, an augmented reality application that allowed users to send photo and video messages. That platform gained more than a million followers in a single year and was purchased by Wayfair in 2016. The company went on to use the app’s AR technology so shoppers could visualize purchases in their space. Carl and I moved to Wayfair, too, where I led product strategy and development for the biggest mobile app team in Boston. Then I had an experience that changed everything. I’m a first-generation American. When my parents moved to the States from Greece, they had to learn a lot while raising me and my sister.

We’re a close family but navigating the world together in this way made us that much closer. So, when my mother was diagnosed with stage 4 brain cancer, we were just floored. That experience was a powerful and deep dive into the American healthcare system. All my years of startup and technology experience taught me to ask questions about everything. Those questions helped add more than two years to my mother’s life, but they also exposed me to a mountain of inefficiencies in our current system. We tend to treat illnesses, but there’s very little conventional treatment to address the factors that can lead to those illnesses. So, I got to work with TrumpIt co-founder Carl Nehme and Dr. Akl Fahed, a cardiologist and scientist at Massachusetts General, to start Goodpath. It’s a mission-driven company aimed at improving Quality Of Life and, honestly, to help people like my own mother take care of themselves in those areas conventional medicine often ignores.


M7: Goodpath’s mission is to improve the ‘Quality Of Life’ for those suffering from chronic conditions. Could you please elaborate on this?
BG:
Have you ever had to stop washing dishes because of the pain in your lower back? Ever had to duck out of an event because of the cramping in your stomach? How many extra coffees have you had this month because you missed out on a few hours of sleep? Those are quality-of-life issues. They’re not emergencies, and they’re not occasional ailments you can cure with an aspirin. They’re somewhere in between, but they’re strong enough to have a real impact on your day-to-day life. That’s what we aim to improve. We do that through integrative care. It’s the medical term for “we treat the whole person” and it’s how we operate. For instance, if you’re in a Goodpath program for back pain, we’re not just treating flare-ups. We’re journaling your experience. We’re accounting for stress. We’re doing yoga and region-specific exercises to loosen muscles. We’re adjusting diets. We’re looking at proven supplements that can help along the way. So, by getting our clients to be proactive in this way – to look at their pain, digestive, and sleep issues in a comprehensive manner – they start taking the initiative to address those quality-of-life issues. No more ducking out of parties, and you can even help with the dishes afterward.


Marketers know all about this because the best marketers are the ones who can honestly put themselves in their customers’ shoes.



M7: Could you please shed some light on Goodpath’s entry in the upcoming ‘Health and Wellness Web Seminar Series’ with Employee Benefit News & Employee Benefit Adviser, in September 2021?
BG
: Absolutely. We’re very fortunate to be able to partner with Employee Benefit News on this project. The web seminar will focus on whole-person care – not as a replacement to conventional care, but as a complement to it. We’ve found that the cost of musculoskeletal treatments is going to rise significantly in the coming years, so we’re sharing with employers how they can curb some of those costs and provide a benefits package that keeps their employees healthier. There are some really bright minds from Goodpath giving the presentation, and you can sign up here. The date is  Tuesday, September 21, 2021.


M7: What might be the reason that chronic conditions such as back pain and digestive issues are undertreated? To what extent has the COVID-19 pandemic aggravated these disorders?
BG:
It’s that in-between scenario again. Primary care physicians only have so much bandwidth, and since most folks don’t go to a doctor until they’re ill, these conditions often go undertreated. Sometimes you’ll see a specialist, but that’s often disconnected from your primary care in a way that removes it from your general care equation. So, we tend to let these things go. We miss sleep. We ‘walk it off’ again and again. We live on a pill and a prayer. And all the while, these nagging issues become something that compound, ultimately impacting everything else in our bodies (and multiplying those quality-of-life issues). And the pandemic is a big driver in the increase of these conditions. Many people are working from home. Stress levels are outrageous. Global studies are proving that sleep issues are widespread because of the pandemic. All that leads up to lost sleep, lots of slouching, poor digestion, and a boatload of stress, which further contributes to pain, digestive issues, and sleep loss. It’s a vicious, vicious cycle.


Many people are working from home. Stress levels are outrageous. Global studies are proving that sleep issues are widespread because of the pandemic.



M7: What are the major advertising and marketing tools you use to hike up the brand awareness of your company?
BG:
Glad you asked! Follow us on Twitter and LinkedIn. Seriously though, we have a fantastic CMO on board who is guiding our multi-channel approach. We keep expanding our awareness marketing with more webinars, conferences, PR, inbound, etc. We’re a research-backed company, so we’re also providing industry-relevant reports (you can see our studies on MSK costs and sleep on our website).  We also have some excited clients who help with person-to-person and company-to-company word of mouth.


M7: It is said that “Empathy is one of the greatest tools of business.” and Goodpath exemplifies it. Could you please share your perspective with our readers starting with their careers?
BG:
There’s truth in that statement. Marketers know all about this because the best marketers are the ones who can honestly put themselves in their customers’ shoes. Good doctors are often ‘good doctors’ because they have empathy. The teachers you remember most are the ones who connected learning to your life. If you’re just starting out in any field, my advice is simple: always try to understand – and empathize with – whoever it is you’re serving. Emulating a hero CEO is fine. Honing your ‘boss energy’ is fine. But if you don’t do your work with your end-user in mind (and at heart), you’ll miss the mark every time.

ABOUT GOODPATH

Goodpath improves the quality of life for members and reduces costs for employers through a personalized, technology-driven, and comprehensive approach to common health conditions, including MSK, Sleep, and Digestive Health. They improve the lives of people managing common health conditions with personalized self-care programs that are easy to use and doctor-approved.

More C-Suite on deck

Q&A with Matthew Sappern, CEO at PeriGen

Media 7 | September 30, 2021

Matthew Sappern, CEO at PeriGen, had served as a corporate officer for Eclipsys Corporation before and during its merger with Allscripts. Leading up to the merger, Sappern served as Eclipsys Senior Vice President of Professional Services, responsible for the company’s $100M consulting, implementation and training P&L. Sappern joined Eclipsys in January 2003, as VP of product development in the software engineering division. Over a time of three years, he came to run 75 percent of the development operation and oversaw the delivery of three critical enterprise software releases in record time for the company.

Read More

Q&A with Anna Baecklund, CTO & Founder at Oppioo

Media 7 | September 21, 2021

Anna Baecklund, CTO & Founder at Oppioo, is a Data Scientist Leader, A skilled communicator capable of explaining complex issues with clarity to diverse audiences. With MSc in engineering physics, Anna is responsible for leading innovation using data science including the development of new insights, advanced modelling techniques, and AI capabilities. With Oppio, An AI companion app, she aims to motivate cancer patients who want to speed up and improve their rehab.

Read More

Q&A with Paula Muto, Founder and CEO of UBERDOC Inc.

September 6, 2021

Paula Muto, M.D., F.A.C.S., Founder and CEO of UBERDOC, is also the Director of the Vein Center at Mutosurgical. A graduate of Amherst College and New York Medical College, Dr. Muto is a fellowship-trained vascular surgeon by specialty who also practices general surgery. Paula is an advocate of disruption in healthcare and speaks passionately on many issues regarding transparency in healthcare, patient rights, and ensuring patient access to the care they need and deserve.

Read More

Q&A with Matthew Sappern, CEO at PeriGen

Media 7 | September 30, 2021

Matthew Sappern, CEO at PeriGen, had served as a corporate officer for Eclipsys Corporation before and during its merger with Allscripts. Leading up to the merger, Sappern served as Eclipsys Senior Vice President of Professional Services, responsible for the company’s $100M consulting, implementation and training P&L. Sappern joined Eclipsys in January 2003, as VP of product development in the software engineering division. Over a time of three years, he came to run 75 percent of the development operation and oversaw the delivery of three critical enterprise software releases in record time for the company.

Read More

Q&A with Anna Baecklund, CTO & Founder at Oppioo

Media 7 | September 21, 2021

Anna Baecklund, CTO & Founder at Oppioo, is a Data Scientist Leader, A skilled communicator capable of explaining complex issues with clarity to diverse audiences. With MSc in engineering physics, Anna is responsible for leading innovation using data science including the development of new insights, advanced modelling techniques, and AI capabilities. With Oppio, An AI companion app, she aims to motivate cancer patients who want to speed up and improve their rehab.

Read More

Q&A with Paula Muto, Founder and CEO of UBERDOC Inc.

September 6, 2021

Paula Muto, M.D., F.A.C.S., Founder and CEO of UBERDOC, is also the Director of the Vein Center at Mutosurgical. A graduate of Amherst College and New York Medical College, Dr. Muto is a fellowship-trained vascular surgeon by specialty who also practices general surgery. Paula is an advocate of disruption in healthcare and speaks passionately on many issues regarding transparency in healthcare, patient rights, and ensuring patient access to the care they need and deserve.

Read More

Related News

HEALTH TECHNOLOGY

Apollo Launches Next-Generation Platform for Rapid Insights in Healthcare and Life Sciences

Businesswire | June 01, 2023

Apollo Intelligence (Apollo), a leading provider of real-time global data and insights to the healthcare and life science industries, announces the launch of its next-generation market insights technology platform to support rapid insights and data collection in the healthcare and life science industries. The advanced platform is fueled by the company’s ongoing investments in its core technologies, propelled by machine learning (ML) and artificial intelligence (AI). With a modern enterprise data architecture, built from best-in-class technologies, Apollo’s next-generation platform provides customers with advanced capabilities to support their progressive insight and data needs. The platform uses ML sampling intelligence to reach global healthcare professional (HCP) panelists with higher efficiency, offering the right research opportunities to the right HCP stakeholders, at the right place and time. This new, advanced capability fosters a seamless cycle of targeted interaction and ongoing engagement that enables greater speed-to-insight and higher quality data. For HCPs, Apollo’s enhanced routing capabilities mean they receive more relevant and matched opportunities to share their expertise and amplify their voice. Capabilities currently rolling out in beta include natural language processing (NLP) advancements in open text analysis for tagging, coding, ML-enhanced adverse event (AE) detection, and reporting. ML-based honoraria optimization for panel engagement. dynamic profiling and validation. In the second half of 2023, these foundational capabilities will support further ML and AI advancements focused on sentiment analysis for free text, survey automation, and expanded global capabilities. “Apollo has been on a multi-year, multimillion-dollar journey building towards this moment when our investments in data and technology would allow us to take advantage of advances in machine learning and data science applications to provide our clients with an unmatched service experience,” said Daniel S. Fitzgerald, president and CEO of Apollo Intelligence. “Life science companies will be able to see the immediate impact in speed and data quality as we leverage machine learning to intelligently sample our HCP communities for data collection. These advances are just the beginning for Apollo as we continue our innovative journey and extend our robust roadmap to deliver higher quality data, speed-to-insight, and advanced analytics and data visualization for our clients.” Apollo has made sizable investments in its platform since 2019 in anticipation of this launch. Its relationship with Frazier Healthcare Partners, in June 2022, has accelerated investment in these areas, with Frazier and Apollo sharing a vision for technological innovation within the healthcare data and insights market. The Frazier Data and AI Center of Excellence has been an instrumental partner in rapidly advancing these modern elements and realizing Apollo’s technology vision. Apollo Intelligence Apollo’s mission is to accelerate health innovation to improve life. In 2019, Apollo launched with the acquisition of InCrowd, a pioneer of real-time, automated insights for the life science industry. In 2020, Apollo strengthened its global reach by acquiring Survey Healthcare Global, a global market leader of first-party healthcare data collection and custom survey solutions. Apollo provides access to 2 million healthcare stakeholders worldwide—including physicians, patients, caregivers, and allied healthcare professionals. Apollo’s 250+ employees support top global pharmaceutical brands, market research agencies, and consultancies across 13 different countries in the Americas, Europe, and Asia. Apollo is a portfolio company of Frazier Healthcare Partners.

Read More

HEALTH TECHNOLOGY, HEALTHCARE ANALYTICS

Marpai Launches Marpai Connect Platform to Predict and Help Modify Risk in Healthcare

PRNewswire | May 31, 2023

Marpai, Inc. an artificial intelligence (AI)-powered healthcare payer transforming self-funded employer health plans, is proud to announce the launch of its innovative platform, Marpai Connect. Marpai Connect, an AI and data-driven matchmaking platform, actively pairs health plan members with an array of value-based providers. Marpai Connect offers self-insured employers a way to reduce risk and cost associated with their healthcare spending. Marpai Connect will be a core part of Marpai's offerings within health plans that it manages for self-insured employers. It includes analytics to measure the impact of the value-based solutions over time versus the current trend. Marpai also intends to offer Marpai Connect to other healthcare payers starting in Q4 of this year. "We realized that chronic diseases are currently representing 41% of the cost across our book of business", said Lutz Finger, Marpai's President of Product and Development. To address those costs, Marpai Connect started to partner with the best value-based solutions for chronic conditions. As of June 2023, Marpai Connect will offer more new vendors. Edmundo Gonzalez, CEO of Marpai, emphasized, "There are amazing, evidence-based solutions that are very specific to a condition, like diabetes, but our clients need a portfolio of solutions covering all the cost drivers of a health plan. That's what Marpai Connect delivers." To monitor the cost drivers, Marpai Connect has created a new AI driven forecasting solution so that Marpai Connect clients can keep track of the reduction of cost. The cornerstone of Marpai Connect's distinctive approach is its use of advanced deep learning technologies, which enable the proactive identification and outreach of health plan members in need. "Marpai Connect is not just about reporting cost trends, rather we're helping plan members improve their health and this leads to savings for employers," asserted Mr. Gonzalez. Marpai Connect aims to create more quality life years for its members. "We have ambitious plans", said Mr. Finger. "We aim to grow our value-based-care network to cover more than 15 different disease states." The launch of Marpai Connect signifies Marpai's dedication to revolutionizing the healthcare industry. By harnessing AI and data, Marpai is transforming the landscape of self-funded health plans, providing a higher quality of care while effectively managing costs. About Marpai, Inc. Marpai, Inc. is an AI-powered Third Party Administrator (TPA) delivering health plan administration and services to employers that directly pay for employee health benefits (self-funded employer health plans). As a technology innovator in the $22 billion TPA sector representing over $1 trillion in annual claims, Marpai includes services beyond traditional TPA services that improve health plan value to members, and significantly reduce medical and pharmaceutical costs for members and the plan.

Read More

HEALTHTECH SECURITY

Carrum Health Raises $45 Million Series B to Expand Cancer Care Offerings and Launch New Service Lines

PRnewsiwire | June 05, 2023

Carrum Health today announced an oversubscribed $45 million Series B financing led by OMERS Growth Equity. Revelation Partners joined the round along with return investors Tiger Global, Wildcat Venture Partners, Cross Creek and SpringRock Ventures. Carrum Health will use the funding to expand its growing oncology benefit offerings and scale its surgical care service lines to give employees access to the top 10% of doctors and providers across the country while helping employers control healthcare spending. Teresa Lee, managing director of OMERS Growth Equity, will join Carrum Health's board of directors. "We are very excited to partner with Carrum Health, a pioneering and differentiated player in the healthcare space, that offers an innovative, scalable approach in the shift to value-based care. With its Centers of Excellence (COE) network, digital platform and data-driven surgical episode bundling capabilities, Carrum Health has created a solution that allows for real-time and measurable value to employers, as well as a superior patient and clinician experience," said Lee. "The company is well-positioned to transform how healthcare is delivered and paid for, and we look forward to supporting the management team in realizing that vision." Carrum Health's unique value-based program addresses acute care scenarios, such as orthopedic surgery and cancer treatment, which accounts for nearly half of total employer spend. Carrum Health's COE solution not only reduces unnecessary procedures by as much as 30%, leading to better patient outcomes, it can result in savings of up to 45% per care episode, according to a published study by the RAND Corporation. "Every business in America is looking to manage costs, but they can't afford to sacrifice the benefits they offer employees. Carrum Health firmly believes that the path to reducing healthcare costs starts with delivering higher quality care," said Carrum Health CEO Sach Jain. "Our COE solution is proven to deliver significant savings on healthcare spend and generate measurable cost savings within the first year of deployment. In a time when employers are looking to consolidate benefits, we've seen 100% year-over-year growth in new customers and zero churn of existing customers." Carrum Health has seen formidable momentum with its pioneering oncology COE offering and currently partners with top cancer care providers across the country, including AccessHope LLC, City of Hope, GRAIL LLC, Memorial Sloan Kettering Cancer Center and University of Chicago Medicine. In 2022 alone, the company added six new partners, including CVS, Included Health, Accolade, Rightway, SWORD Health and Virgin Pulse. About Carrum Health Carrum Health is a value-based healthcare platform delivering higher quality care while helping self-funded employers immediately reduce their spend for the most prevalent and costly conditions including cancer, musculoskeletal, cardiovascular, and bariatric. Utilizing a Centers of Excellence (COE) network, with an all-inclusive pricing model and 30-day warranty on care, Carrum members receive surgical and cancer treatment guidance and coordination through the entire care journey with upfront pricing, ensuring the highest quality, most appropriate care. Carrum reduces unnecessary procedures by as much as 30% and aligns cost and care incentives to save employers up to 45% per episode of care, all validated by peer-reviewed publications. Carrum's award-winning technology gives members access to a mobile app and Care Specialist that guides them through the surgery process, and a seamless platform integration to make COE adoption plug-and-play for employers. Backed by OMERS Growth Equity and Tiger Global, Carrum was named to the 2021 CB Insights Digital Health 150 and named one of the best places to work in 2022 by Built In. The company, founded in 2014, is headquartered in Silicon Valley.

Read More

HEALTH TECHNOLOGY

Apollo Launches Next-Generation Platform for Rapid Insights in Healthcare and Life Sciences

Businesswire | June 01, 2023

Apollo Intelligence (Apollo), a leading provider of real-time global data and insights to the healthcare and life science industries, announces the launch of its next-generation market insights technology platform to support rapid insights and data collection in the healthcare and life science industries. The advanced platform is fueled by the company’s ongoing investments in its core technologies, propelled by machine learning (ML) and artificial intelligence (AI). With a modern enterprise data architecture, built from best-in-class technologies, Apollo’s next-generation platform provides customers with advanced capabilities to support their progressive insight and data needs. The platform uses ML sampling intelligence to reach global healthcare professional (HCP) panelists with higher efficiency, offering the right research opportunities to the right HCP stakeholders, at the right place and time. This new, advanced capability fosters a seamless cycle of targeted interaction and ongoing engagement that enables greater speed-to-insight and higher quality data. For HCPs, Apollo’s enhanced routing capabilities mean they receive more relevant and matched opportunities to share their expertise and amplify their voice. Capabilities currently rolling out in beta include natural language processing (NLP) advancements in open text analysis for tagging, coding, ML-enhanced adverse event (AE) detection, and reporting. ML-based honoraria optimization for panel engagement. dynamic profiling and validation. In the second half of 2023, these foundational capabilities will support further ML and AI advancements focused on sentiment analysis for free text, survey automation, and expanded global capabilities. “Apollo has been on a multi-year, multimillion-dollar journey building towards this moment when our investments in data and technology would allow us to take advantage of advances in machine learning and data science applications to provide our clients with an unmatched service experience,” said Daniel S. Fitzgerald, president and CEO of Apollo Intelligence. “Life science companies will be able to see the immediate impact in speed and data quality as we leverage machine learning to intelligently sample our HCP communities for data collection. These advances are just the beginning for Apollo as we continue our innovative journey and extend our robust roadmap to deliver higher quality data, speed-to-insight, and advanced analytics and data visualization for our clients.” Apollo has made sizable investments in its platform since 2019 in anticipation of this launch. Its relationship with Frazier Healthcare Partners, in June 2022, has accelerated investment in these areas, with Frazier and Apollo sharing a vision for technological innovation within the healthcare data and insights market. The Frazier Data and AI Center of Excellence has been an instrumental partner in rapidly advancing these modern elements and realizing Apollo’s technology vision. Apollo Intelligence Apollo’s mission is to accelerate health innovation to improve life. In 2019, Apollo launched with the acquisition of InCrowd, a pioneer of real-time, automated insights for the life science industry. In 2020, Apollo strengthened its global reach by acquiring Survey Healthcare Global, a global market leader of first-party healthcare data collection and custom survey solutions. Apollo provides access to 2 million healthcare stakeholders worldwide—including physicians, patients, caregivers, and allied healthcare professionals. Apollo’s 250+ employees support top global pharmaceutical brands, market research agencies, and consultancies across 13 different countries in the Americas, Europe, and Asia. Apollo is a portfolio company of Frazier Healthcare Partners.

Read More

HEALTH TECHNOLOGY, HEALTHCARE ANALYTICS

Marpai Launches Marpai Connect Platform to Predict and Help Modify Risk in Healthcare

PRNewswire | May 31, 2023

Marpai, Inc. an artificial intelligence (AI)-powered healthcare payer transforming self-funded employer health plans, is proud to announce the launch of its innovative platform, Marpai Connect. Marpai Connect, an AI and data-driven matchmaking platform, actively pairs health plan members with an array of value-based providers. Marpai Connect offers self-insured employers a way to reduce risk and cost associated with their healthcare spending. Marpai Connect will be a core part of Marpai's offerings within health plans that it manages for self-insured employers. It includes analytics to measure the impact of the value-based solutions over time versus the current trend. Marpai also intends to offer Marpai Connect to other healthcare payers starting in Q4 of this year. "We realized that chronic diseases are currently representing 41% of the cost across our book of business", said Lutz Finger, Marpai's President of Product and Development. To address those costs, Marpai Connect started to partner with the best value-based solutions for chronic conditions. As of June 2023, Marpai Connect will offer more new vendors. Edmundo Gonzalez, CEO of Marpai, emphasized, "There are amazing, evidence-based solutions that are very specific to a condition, like diabetes, but our clients need a portfolio of solutions covering all the cost drivers of a health plan. That's what Marpai Connect delivers." To monitor the cost drivers, Marpai Connect has created a new AI driven forecasting solution so that Marpai Connect clients can keep track of the reduction of cost. The cornerstone of Marpai Connect's distinctive approach is its use of advanced deep learning technologies, which enable the proactive identification and outreach of health plan members in need. "Marpai Connect is not just about reporting cost trends, rather we're helping plan members improve their health and this leads to savings for employers," asserted Mr. Gonzalez. Marpai Connect aims to create more quality life years for its members. "We have ambitious plans", said Mr. Finger. "We aim to grow our value-based-care network to cover more than 15 different disease states." The launch of Marpai Connect signifies Marpai's dedication to revolutionizing the healthcare industry. By harnessing AI and data, Marpai is transforming the landscape of self-funded health plans, providing a higher quality of care while effectively managing costs. About Marpai, Inc. Marpai, Inc. is an AI-powered Third Party Administrator (TPA) delivering health plan administration and services to employers that directly pay for employee health benefits (self-funded employer health plans). As a technology innovator in the $22 billion TPA sector representing over $1 trillion in annual claims, Marpai includes services beyond traditional TPA services that improve health plan value to members, and significantly reduce medical and pharmaceutical costs for members and the plan.

Read More

HEALTHTECH SECURITY

Carrum Health Raises $45 Million Series B to Expand Cancer Care Offerings and Launch New Service Lines

PRnewsiwire | June 05, 2023

Carrum Health today announced an oversubscribed $45 million Series B financing led by OMERS Growth Equity. Revelation Partners joined the round along with return investors Tiger Global, Wildcat Venture Partners, Cross Creek and SpringRock Ventures. Carrum Health will use the funding to expand its growing oncology benefit offerings and scale its surgical care service lines to give employees access to the top 10% of doctors and providers across the country while helping employers control healthcare spending. Teresa Lee, managing director of OMERS Growth Equity, will join Carrum Health's board of directors. "We are very excited to partner with Carrum Health, a pioneering and differentiated player in the healthcare space, that offers an innovative, scalable approach in the shift to value-based care. With its Centers of Excellence (COE) network, digital platform and data-driven surgical episode bundling capabilities, Carrum Health has created a solution that allows for real-time and measurable value to employers, as well as a superior patient and clinician experience," said Lee. "The company is well-positioned to transform how healthcare is delivered and paid for, and we look forward to supporting the management team in realizing that vision." Carrum Health's unique value-based program addresses acute care scenarios, such as orthopedic surgery and cancer treatment, which accounts for nearly half of total employer spend. Carrum Health's COE solution not only reduces unnecessary procedures by as much as 30%, leading to better patient outcomes, it can result in savings of up to 45% per care episode, according to a published study by the RAND Corporation. "Every business in America is looking to manage costs, but they can't afford to sacrifice the benefits they offer employees. Carrum Health firmly believes that the path to reducing healthcare costs starts with delivering higher quality care," said Carrum Health CEO Sach Jain. "Our COE solution is proven to deliver significant savings on healthcare spend and generate measurable cost savings within the first year of deployment. In a time when employers are looking to consolidate benefits, we've seen 100% year-over-year growth in new customers and zero churn of existing customers." Carrum Health has seen formidable momentum with its pioneering oncology COE offering and currently partners with top cancer care providers across the country, including AccessHope LLC, City of Hope, GRAIL LLC, Memorial Sloan Kettering Cancer Center and University of Chicago Medicine. In 2022 alone, the company added six new partners, including CVS, Included Health, Accolade, Rightway, SWORD Health and Virgin Pulse. About Carrum Health Carrum Health is a value-based healthcare platform delivering higher quality care while helping self-funded employers immediately reduce their spend for the most prevalent and costly conditions including cancer, musculoskeletal, cardiovascular, and bariatric. Utilizing a Centers of Excellence (COE) network, with an all-inclusive pricing model and 30-day warranty on care, Carrum members receive surgical and cancer treatment guidance and coordination through the entire care journey with upfront pricing, ensuring the highest quality, most appropriate care. Carrum reduces unnecessary procedures by as much as 30% and aligns cost and care incentives to save employers up to 45% per episode of care, all validated by peer-reviewed publications. Carrum's award-winning technology gives members access to a mobile app and Care Specialist that guides them through the surgery process, and a seamless platform integration to make COE adoption plug-and-play for employers. Backed by OMERS Growth Equity and Tiger Global, Carrum was named to the 2021 CB Insights Digital Health 150 and named one of the best places to work in 2022 by Built In. The company, founded in 2014, is headquartered in Silicon Valley.

Read More

Spotlight

Goodpath

Goodpath

Goodpath improves the quality of life for members and reduces costs for employers through a personalized, technology-driven, and comprehensive approach to common health conditions, including MSK, Sleep, and Digestive Health. They improve the lives of people managing common health conditions with per...

Events

Resources

resource image

FUTURE OF HEALTHCARE, MEDICAL DEVICES

A vision for Medical Affairs in 2025

Whitepaper

resource image

FUTURE OF HEALTHCARE, DIGITAL HEALTHCARE

rf IDEAS WAVE ID Solutions for Healthcare

Video

resource image

FUTURE OF HEALTHCARE, HEALTHCARE ANALYTICS

A new era for healthcare infrastructure

Video

resource image

FUTURE OF HEALTHCARE, MEDICAL DEVICES

A vision for Medical Affairs in 2025

Whitepaper

resource image

FUTURE OF HEALTHCARE, DIGITAL HEALTHCARE

rf IDEAS WAVE ID Solutions for Healthcare

Video

resource image

FUTURE OF HEALTHCARE, HEALTHCARE ANALYTICS

A new era for healthcare infrastructure

Video

Events